Literature DB >> 16341992

Transient ischemic attack: a dangerous Harbinger and an opportunity to intervene.

S Claiborne Johnston1.   

Abstract

Transient ischemic attack (TIA) and ischemic stroke are both characterized by sudden onset of neurological symptoms due to focal cerebral ischemia, but they are distinguished by the duration of neurological symptoms, with TIA traditionally defined by resolution of symptoms within 24 hours and stroke reserved for symptoms of longer duration. Because TIA and ischemic stroke share etiologies, it is not surprising that the recommended evaluations and secondary prophylaxis are identical. However, recent studies suggest that optimal management of TIA and stroke may differ more than previously recognized. The short-term risk of ischemic stroke after TIA is very high, which may be because rapid recovery from neurological symptoms is indicative of reversal of ischemia and tissue still at risk. Regardless of whether residual symptoms or infarction are present, rapid recovery appears to predict a greater short-term risk of subsequent ischemic stroke and is more likely to reflect a distinct, unstable pathophysiology. Therefore, it may be more useful to characterize acute ischemic cerebrovascular syndromes on the basis of the extent of rapid recovery (i.e., on the inferred reversal of ischemia) than on the completeness of recovery at 24 hours. Patients with substantial rapid recovery may be those for whom acute intervention is most warranted.

Entities:  

Mesh:

Year:  2005        PMID: 16341992     DOI: 10.1055/s-2005-923530

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  2 in total

1.  Interleukin-6 mediates enhanced thrombus development in cerebral arterioles following a brief period of focal brain ischemia.

Authors:  Ya Hui Tang; Shantel Vital; Janice Russell; Hilary Seifert; D Neil Granger
Journal:  Exp Neurol       Date:  2015-06-05       Impact factor: 5.330

2.  Transient ischemia elicits a sustained enhancement of thrombus development in the cerebral microvasculature: effects of anti-thrombotic therapy.

Authors:  Ya Hui Tang; Shantel Vital; Janice Russell; Hilary Seifert; Elena Senchenkova; D Neil Granger
Journal:  Exp Neurol       Date:  2014-07-21       Impact factor: 5.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.